* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Download Characterization of disease-causing dendritic cells in Crohn`s
Ulcerative colitis wikipedia , lookup
Traveler's diarrhea wikipedia , lookup
Periodontal disease wikipedia , lookup
Crohn's disease wikipedia , lookup
Sociality and disease transmission wikipedia , lookup
Neuromyelitis optica wikipedia , lookup
Adoptive cell transfer wikipedia , lookup
Management of multiple sclerosis wikipedia , lookup
Innate immune system wikipedia , lookup
Cancer immunotherapy wikipedia , lookup
Ankylosing spondylitis wikipedia , lookup
Pathophysiology of multiple sclerosis wikipedia , lookup
Inflammation wikipedia , lookup
Multiple sclerosis research wikipedia , lookup
Rheumatoid arthritis wikipedia , lookup
Multiple sclerosis signs and symptoms wikipedia , lookup
Hygiene hypothesis wikipedia , lookup
Psychoneuroimmunology wikipedia , lookup
M.Sarfati CCFC 2010 Project Title: Characterization of disease-causing dendritic cells in Crohn's disease Lay Summary: Crohn’s disease (CD) is a chronic inflammatory intestinal disorder with no known cure. The inflammation characteristic of CD can be found anywhere along the digestive tract, and is thought to result from an inappropriate immune response in genetically-prone individuals. Its incidence is rising in Canada, where its prevalence is said to be among the highest in the world. CD patients experience severe symptoms such as abdominal pain, nausea/vomiting and diarrhea. The currently available therapies for CD are often associated with serious side effects and highlight the need for continued research in this field. Dendritic cells (DCs) are a specialized cell type primarily located within tissues that are in contact with the external environment, such as the gut. They participate in discriminating between harmful and harmless external threats. Therefore, when dysregulated, DCs may misinterpret a harmless encounter and initiate an immune response, leading to chronic intestinal inflammation. We recently identified a subset of DCs (SIRP-α+ DCs), which promote intestinal inflammation in a mouse model of CD. Therefore, the identification of the human counterpart of SIRPα+ DCs in mice may contribute to our knowledge of the development of IBD. The purpose of this study is to characterize these DCs in human intestinal tissue of CD and healthy patients. The study will also compare the function of these DCs in blood and those isolated from intestinal tissues. Other than extending our scientific knowledge of IBD, this work may translate into the development of new therapeutic targets for IBD patients.